ZOETIS INC
ZOETIS INC
Sector: Healthcare
Description
Zoetis Inc (NYSE: ZTS) commercializes, develops, discovers, and manufactures animal vaccines, health medicines for animals and livestock.
The company earlier operated under its parent Pfizer. In 2013, Pfizer divested its animal health business to a separate company, known as Zoetis Inc. It went public in 2013 and was listed on the New York Stock Exchange.
The company sells its products globally, including Africa, North America, Asia, Latin America, and Australia.
It produces, sells, and develops vaccines, medicines, and diagnostic products. Zoetis Inc claims to provide industry-leading medical products for animal health. It caters to eight therapeutic areas in animal healthcare and well-being.
The animal healthcare provider company operates in the health care sector and biotech and pharma sub-industry.
It was formerly known as Pfizer Animal Health until the spin-off in 2013. The company reportedly became a leading animal health solutions provider in the world. Zoetis Inc was also included among 500 top companies in the United States in S&P index.
The company’s products and services cater to fish, cattle, poultry, sheep, pigs, and other livestock.
The global healthcare firm operates through several subsidiaries, including Zoetis Belgium S.A, Phoenix Central Laboratory For Veterinarians Inc., Zoentis Denmark ApS, Zoetis Medolla Manufacturing, etc.
Zoetis Inc reportedly has been providing world-class products for improving the healthcare of animals for over 65 years now. It also claims to have US$ 1 million scholarships for students.
Zoetis Inc also offers various services such as e-learning, data management, and professional consulting. The global firm provides customer service, business support, and technical education to the ones engaged in animal care.
It was reportedly among 25 Best Companies for Latino and America’s Best Employers for 2021.
As part of its sustainability commitments, the company claim to source 100 percent renewable energy by 2050 across its business operations. In addition, Zoetis Inc aims to reduce energy intensity in manufacturing and integrate sustainable packaging by 2025.
Peers

OCA
Oceania Healthcare Limited

NVAX
Novavax Inc

AFT
AFT Pharmaceuticals Limited

ANP
Antisense Therapeutics Ltd.

PTX
Prescient Therapeutics Limited

MRNA
Moderna Inc

CVT
Comvita Limited

PEB
Pacific Edge Limited

NOX
Noxopharm Limited

IMU
Imugene Limited

SKN
Skin Elements Ltd

ORPH
Open Orphan Plc